Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

@article{Gray2010ProtonPI,
  title={Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.},
  author={Shelly L. Gray and Andrea Z LaCroix and Joseph R Larson and John Robbins and Jane A. Cauley and Joann E. Manson and Zhao Chen},
  journal={Archives of internal medicine},
  year={2010},
  volume={170 9},
  pages={765-71}
}
BACKGROUND Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. We examined the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]). METHODS This prospective analysis included 161 806 postmenopausal women 50 to 79 years old, without history of hip fracture, enrolled in the Women's Health Initiative (WHI) Observational Study and Clinical Trials with a mean (SD) follow-up of 7.8 (1.6) years. Analyses… CONTINUE READING
125 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 125 extracted citations

Similar Papers

Loading similar papers…